PGNY — what changed in the latest 10-Q
A section-by-section comparison of PGNY's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-05-08 vs the prior 10-Q · 2025-11-07
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +19 | −28 | ~20 | 36 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 3 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Risk factors | Text added/removed | +4 | −2 | ~30 | 183 |
| Other information | Text added/removed | 0 | 0 | ~2 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Legal proceedings
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-05-08
Our Clients. We currently serve over 590 employers with at least 1,000 covered lives in the United States across more than 40 industries, including technology, consumer retail, e-commerce, industrial, healthcare, media, insurance, legal, food and beverage, financial services, life sciences, professi…
We continue to expand our women's health and family building solutions to include pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. While these offerings represent strategic areas of investment, they were not a significant portio…
Revenue increased by $4.5 million, or 1%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. This increase is primarily due to a $3.0 million, or 1%, increase in revenue from our fertility benefits solution and a $1.5 million, or 1%, increase in revenue from…
Cost of services decreased by $2.8 million, or 1%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025. This decrease was primarily due to a reduction in medical treatment and pharmacy prescription costs associated with fertility treatments delivered driven by…
Gross profit increased by $7.3 million, or 10%, for the three months ended March 31, 2026 compared to the three months ended March 31, 2025.
Text removed vs the prior filing · source: 10-Q · 2025-11-07
Our Clients. We currently serve over 550 employers with at least 1,000 covered lives in the United States across more than 40 industries. Our current clients, who are industry leaders across both high-growth and mature industries and who range in size from approximately 1,000 to 600,000 employees, r…
Comparison of Three Months Ended September 30, 2025 and 2024
Revenue increased by $26.7 million, or 9%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024. This increase is primarily due to a $23.2 million, or 13%, increase in revenue from our fertility benefits solution and a $3.5 million, or 3%, increase in r…
Cost of services increased by $13.1 million, or 6%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily due to an increase in medical treatment and pharmacy prescription costs associated with fertility treatment delivered. This increase in c…
Gross profit increased by $13.6 million, or 23%, for the three months ended September 30, 2025 compared to the three months ended September 30, 2024.
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-05-08
We currently have contracts to serve over 590 employers with at least 1,000 covered lives in the United States across more than 40 industries. Our largest clients account for a significant portion of our revenue. In addition, a significant number of our clients are in the technology industry, and we…
Our use of artificial intelligence may subject us to new or heightened legal, regulatory, ethical, operational or other challenges.
We use, and may in the future continue to use, artificial intelligence (“AI”), including generative AI, in connection with our business and operations, including for internal operational and productivity improvement business purposes. There are significant risks involved in utilizing AI, the develop…
Regulation of AI is rapidly evolving worldwide and may change the competitive landscape of our and many other industries. AI is also an area of increased focus for legislators and regulators as this emerging technology develops. The technologies underlying AI and its uses are already subject to a va…
Text removed vs the prior filing · source: 10-Q · 2025-11-07
We currently have contracts to serve over 550 employers with at least 1,000 covered lives in the United States across more than 40 industries. For the nine months ended September 30, 2025, no client accounted for more than 10% of our total revenue. For the nine months ended September 30, 2024, one o…
Engagement with these clients is generally covered through contracts that are multi-year in duration. These clients may terminate early or decline to renew their existing contracts with us upon expiration, and any such termination or failure to renew could have a negative impact on our revenue and i…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice